Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Alopecia, Hypotrichosis, Madarosis
Clinical narrative: After receiving Moderna Covid-19 vaccine, started losing his hair; had a mustache and now does not have any facial hair at all, including eyebrows or hair on this head; After receiving Moderna Covid-19 vaccine, started losing his hair; had a mustache and now does not have any facial hair at all, including eyebrows or hair on this head/started loosing eye lashes and eye brows; After receiving Moderna Covid-19 vaccine, started losing his hair; had a mustache and now does not have any facial hair at all, including eyebrows or hair on this head,he was completly bald/Excessive loss of hair; noticed hair might be thinning; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 05-Jul-2021. The most recent information was received on 29-Jul-2021 and was forwarded to Moderna on 29-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MADAROSIS (After receiving Moderna Covid-19 vaccine, started losing his hair; had a mustache and now does not have any facial hair at all, including eyebrows or hair on this head/started loosing eye lashes and eye brows), ALOPECIA (After receiving Moderna Covid-19 vaccine, started losing his hair; had a mustache and now does not have any facial hair at all, including eyebrows or hair on this head,he was completly bald/Excessive loss of hair), HYPOTRICHOSIS (After receiving Moderna Covid-19 vaccine, started losing his hair; had a mustache and now does not have any facial hair at all, including eyebrows or hair on this head) and ALOPECIA (noticed hair might be thinning) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy. Concomitant products included TOCOPHERYL ACETATE (VITAMIN E-400), VITAMIN C [ASCORBIC ACID], COLECALCIFEROL (VITAMIN D 3), MENAQUINONE-7 (VITAMIN K 2), VITAMIN B COMPLEX, NIACIN, FISH OIL, CALCIUM and ZINC for an unknown indication, MAGNESIUM.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Feb-2021, the patient experienced ALOPECIA (noticed hair might be thinning). On 09-Mar-2021, the patient experienced ALOPECIA (After receiving Moderna Covid-19 vaccine, started losing his hair; had a mustache and now does not have any facial hair at all, including eyebrows or hair on this head,he was completly bald/Excessive loss of hair). In June 2021, the patient experienced MADAROSIS (After receiving Moderna Covid-19 vaccine, started losing his hair; had a mustache and now does not have any facial hair at all, including eyebrows or hair on this head/started loosing eye lashes and eye brows). On an unknown date, the patient experienced HYPOTRICHOSIS (After receiving Moderna Covid-19 vaccine, started losing his hair; had a mustache and now does not have any facial hair at all, including eyebrows or hair on this head). At the time of the report, MADAROSIS (After receiving Moderna Covid-19 vaccine, started losing his hair; had a mustache and now does not have any facial hair at all, including eyebrows or hair on this head/started loosing eye lashes and eye brows), ALOPECIA (After receiving Moderna Covid-19 vaccine, started losing his hair; had a mustache and now does not have any facial hair at all, including eyebrows or hair on this head,he was completly bald/Excessive loss of hair) and ALOPECIA (noticed hair might be thinning) had not resolved and HYPOTRICHOSIS (After receiving Moderna Covid-19 vaccine, started losing his hair; had a mustache and now does not have any facial hair at all, including eyebrows or hair on this head) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided. Treatment information was not provided.   This case was linked to MOD-2021-248380 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: non-significant On 29-Jul-2021: Follow received included Medical history, concomitant medication and therapy details